The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[3-(2-Hydroxy-3-piperidin-1-yl-propoxy)-phenyl]-3-phenyl-propan-1-one ID: ALA146135
PubChem CID: 11428594
Max Phase: Preclinical
Molecular Formula: C23H29NO3
Molecular Weight: 367.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1ccccc1)c1cccc(OCC(O)CN2CCCCC2)c1
Standard InChI: InChI=1S/C23H29NO3/c25-21(17-24-14-5-2-6-15-24)18-27-22-11-7-10-20(16-22)23(26)13-12-19-8-3-1-4-9-19/h1,3-4,7-11,16,21,25H,2,5-6,12-15,17-18H2
Standard InChI Key: HIWSPAOYMSSPJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
7.9792 0.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -2.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -1.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -2.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2667 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 0.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5500 0.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -0.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8375 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -3.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5417 1.0583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2542 -3.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9667 1.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6917 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -0.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 0.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5500 -3.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2667 -4.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4042 0.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6917 1.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -5.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -3.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4042 1.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -4.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 10 1 0
5 2 2 0
6 2 1 0
7 1 1 0
8 11 1 0
9 7 1 0
10 8 1 0
11 9 1 0
12 6 1 0
13 9 1 0
14 12 1 0
15 1 1 0
16 1 1 0
17 18 2 0
18 19 1 0
19 10 2 0
20 14 2 0
21 14 1 0
22 16 1 0
23 15 1 0
24 21 2 0
25 20 1 0
26 22 1 0
27 24 1 0
23 26 1 0
3 17 1 0
27 25 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.49Molecular Weight (Monoisotopic): 367.2147AlogP: 3.73#Rotatable Bonds: 9Polar Surface Area: 49.77Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.04CX LogP: 3.89CX LogD: 3.16Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -0.80
References 1. Fleischer R, Wiese M.. (2003) Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity., 46 (23): [PMID:14584949 ] [10.1021/jm030876r ] 2. Kaiser D, Terfloth L, Kopp S, Schulz J, de Laet R, Chiba P, Ecker GF, Gasteiger J.. (2007) Self-organizing maps for identification of new inhibitors of P-glycoprotein., 50 (7): [PMID:17352460 ] [10.1021/jm060604z ]